Mono Pharmacare Statistics

Total Valuation

Mono Pharmacare has a market cap or net worth of INR 429.35 million. The enterprise value is 958.32 million.

Market Cap	429.35M
Enterprise Value	958.32M

Important Dates

Earnings Date	n/a
Ex-Dividend Date	n/a

Share Statistics

Mono Pharmacare has 17.67 million shares outstanding. The number of shares has increased by 14.23% in one year.

Current Share Class	17.67M
Shares Outstanding	17.67M
Shares Change (YoY)	+14.23%
Shares Change (QoQ)	+0.23%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	n/a

Valuation Ratios

The trailing PE ratio is 13.89.

PE Ratio	13.89
Forward PE	n/a
PS Ratio	0.25
PB Ratio	1.37
P/TBV Ratio	1.38
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 11.12, with an EV/FCF ratio of -21.16.

EV / Earnings	31.01
EV / Sales	0.57
EV / EBITDA	11.12
EV / EBIT	11.29
EV / FCF	-21.16

Financial Position

The company has a current ratio of 2.07, with a Debt / Equity ratio of 1.71.

Current Ratio	2.07
Quick Ratio	0.81
Debt / Equity	1.71
Debt / EBITDA	6.22
Debt / FCF	-11.83
Interest Coverage	2.11

Financial Efficiency

Return on equity (ROE) is 10.46% and return on invested capital (ROIC) is 6.87%.

Return on Equity (ROE)	10.46%
Return on Assets (ROA)	5.55%
Return on Invested Capital (ROIC)	6.87%
Return on Capital Employed (ROCE)	14.82%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	1.77
Inventory Turnover	3.12

Taxes

In the past 12 months, Mono Pharmacare has paid 13.57 million in taxes.

Income Tax	13.57M
Effective Tax Rate	30.41%

Stock Price Statistics

The stock price has decreased by -36.30% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-36.30%
50-Day Moving Average	24.80
200-Day Moving Average	31.48
Relative Strength Index (RSI)	46.85
Average Volume (20 Days)	26,800

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Mono Pharmacare had revenue of INR 1.69 billion and earned 30.90 million in profits. Earnings per share was 1.75.

Revenue	1.69B
Gross Profit	170.06M
Operating Income	84.88M
Pretax Income	44.63M
Net Income	30.90M
EBITDA	86.17M
EBIT	84.88M
Earnings Per Share (EPS)	1.75

Full Income Statement

Balance Sheet

The company has 6.98 million in cash and 535.60 million in debt, giving a net cash position of -528.63 million or -29.92 per share.

Cash & Cash Equivalents	6.98M
Total Debt	535.60M
Net Cash	-528.63M
Net Cash Per Share	-29.92
Equity (Book Value)	312.34M
Book Value Per Share	17.65
Working Capital	562.12M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -43.03 million and capital expenditures -2.26 million, giving a free cash flow of -45.29 million.

Operating Cash Flow	-43.03M
Capital Expenditures	-2.26M
Free Cash Flow	-45.29M
FCF Per Share	-2.56

Full Cash Flow Statement

Margins

Gross margin is 10.04%, with operating and profit margins of 5.01% and 1.83%.

Gross Margin	10.04%
Operating Margin	5.01%
Pretax Margin	2.64%
Profit Margin	1.83%
EBITDA Margin	5.09%
EBIT Margin	5.01%
FCF Margin	n/a

Dividends & Yields

Mono Pharmacare does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-14.23%
Shareholder Yield	n/a
Earnings Yield	7.20%
FCF Yield	-10.55%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	4